Jinhe Biotech: Jinhe Holdings plans to reduce its shareholding in the company by no more than 3%.

Golden River Bios Announcement, controlling shareholder Golden River Holdings plans to reduce its holdings of the company's shares by no more than 22.5634 million shares through centralized bidding and block trading from June 10, 2025 to September 9, 2025, which is not more than 3% of the company's total share capital. Among them, the reduction through centralized bidding does not exceed 7.5211 million shares, accounting for 1% of the total share capital; the reduction through block trading does not exceed 15.0423 million shares, accounting for 2% of the total share capital. The reason for the reduction is to repay the pledged debt, and the reduction price will be determined based on the market price.